Skip to content

Safinamide in Parkinson’s disease: No hint of added benefit

  • by

From the Institute for Quality and Efficiency in Health Care media release: Safinamide (trade name: Xadago) has been available since February 2015 as add-on therapy for the treatment of mid- to late-stage Parkinson disease in adults.… 

Causal connection found between genotypes, years of education achieved

From the American Educational Research Association media release: A first-of-its-kind, nationally representative study of siblings supports previously published research on unrelated individuals that links specific genotypes to educational attainment among adults in their mid-20s to early… 

Uric acid may lessen disability after stroke for women

From the American Heart Association media release: Uric acid — a chemical at high levels can lead to serious illness — may lessen women’s disability after stroke, according to new research in the American Heart…